US Stock MarketDetailed Quotes

Arcus Biosciences (RCUS)

Watchlist
  • 24.900
  • +0.040+0.16%
Close May 12 16:00 ET
  • 24.900
  • 0.0000.00%
Post 16:10 ET
3.13BMarket Cap-7.85P/E (TTM)

Arcus Biosciences (RCUS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-39.29%17M
-4.26%247M
26.92%33M
-45.83%26M
310.26%160M
-80.69%28M
120.51%258M
-16.13%26M
50.00%48M
34.48%39M
Operating revenue
-39.29%17M
-4.26%247M
26.92%33M
-45.83%26M
310.26%160M
-80.69%28M
120.51%258M
-16.13%26M
50.00%48M
34.48%39M
Cost of revenue
Gross profit
Operating expense
0.67%151M
11.44%633M
13.95%147M
9.80%168M
15.86%168M
6.38%150M
24.29%568M
5.74%129M
36.61%153M
29.46%145M
Selling and administrative expenses
3.57%29M
-8.33%110M
-7.14%26M
-10.00%27M
-3.33%29M
-12.50%28M
2.56%120M
-3.45%28M
0.00%30M
7.14%30M
-General and administrative expense
3.57%29M
-8.33%110M
-7.14%26M
-10.00%27M
-3.33%29M
-12.50%28M
2.56%120M
-3.45%28M
0.00%30M
7.14%30M
Research and development costs
0.00%122M
16.74%523M
19.80%121M
14.63%141M
20.87%139M
11.93%122M
31.76%448M
8.60%101M
50.00%123M
36.90%115M
Operating profit
-9.84%-134M
-24.52%-386M
-10.68%-114M
-35.24%-142M
92.45%-8M
-3,150.00%-122M
8.82%-310M
-13.19%-103M
-31.25%-105M
-27.71%-106M
Net non-operating interest income expense
-40.00%6M
-31.25%33M
-20.00%8M
-46.15%7M
-38.46%8M
-16.67%10M
23.08%48M
-9.09%10M
18.18%13M
44.44%13M
Non-operating interest income
-18.18%9M
-21.15%41M
-16.67%10M
-28.57%10M
-23.08%10M
-15.38%11M
26.83%52M
9.09%12M
16.67%14M
44.44%13M
Non-operating interest expense
200.00%3M
100.00%8M
0.00%2M
200.00%3M
--2M
0.00%1M
100.00%4M
--2M
0.00%1M
--0
Other net income (expense)
-20M
0
Special income (charges)
----
--0
--0
--0
--0
--0
---20M
--0
--0
--0
-Less:Impairment of capital assets
----
--0
--0
--0
--0
--0
--20M
--0
--0
--0
Income before tax
-14.29%-128M
-25.18%-353M
-13.98%-106M
-46.74%-135M
0
-2,700.00%-112M
6.31%-282M
-16.25%-93M
-33.33%-92M
-25.68%-93M
Income tax
0
0
0
0
0
0
-83.33%1M
0.00%1M
0
0
Net income
-14.29%-128M
-24.73%-353M
-12.77%-106M
-46.74%-135M
0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
Net income continuous Operations
-14.29%-128M
-24.73%-353M
-12.77%-106M
-46.74%-135M
--0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
Minority interest income
Net income attributable to the parent company
-14.29%-128M
-24.73%-353M
-12.77%-106M
-46.74%-135M
0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.29%-128M
-24.73%-353M
-12.77%-106M
-46.74%-135M
0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
Basic earnings per share
10.53%-1.02
-4.78%-3.29
13.59%-0.89
-27.00%-1.27
0
-2,180.00%-1.14
24.34%-3.14
4.63%-1.03
-6.38%-1
1.92%-1.02
Diluted earnings per share
10.53%-1.02
-4.78%-3.29
13.59%-0.89
-27.00%-1.27
0
-2,180.00%-1.14
24.34%-3.14
4.63%-1.03
-6.38%-1
1.92%-1.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -39.29%17M-4.26%247M26.92%33M-45.83%26M310.26%160M-80.69%28M120.51%258M-16.13%26M50.00%48M34.48%39M
Operating revenue -39.29%17M-4.26%247M26.92%33M-45.83%26M310.26%160M-80.69%28M120.51%258M-16.13%26M50.00%48M34.48%39M
Cost of revenue
Gross profit
Operating expense 0.67%151M11.44%633M13.95%147M9.80%168M15.86%168M6.38%150M24.29%568M5.74%129M36.61%153M29.46%145M
Selling and administrative expenses 3.57%29M-8.33%110M-7.14%26M-10.00%27M-3.33%29M-12.50%28M2.56%120M-3.45%28M0.00%30M7.14%30M
-General and administrative expense 3.57%29M-8.33%110M-7.14%26M-10.00%27M-3.33%29M-12.50%28M2.56%120M-3.45%28M0.00%30M7.14%30M
Research and development costs 0.00%122M16.74%523M19.80%121M14.63%141M20.87%139M11.93%122M31.76%448M8.60%101M50.00%123M36.90%115M
Operating profit -9.84%-134M-24.52%-386M-10.68%-114M-35.24%-142M92.45%-8M-3,150.00%-122M8.82%-310M-13.19%-103M-31.25%-105M-27.71%-106M
Net non-operating interest income expense -40.00%6M-31.25%33M-20.00%8M-46.15%7M-38.46%8M-16.67%10M23.08%48M-9.09%10M18.18%13M44.44%13M
Non-operating interest income -18.18%9M-21.15%41M-16.67%10M-28.57%10M-23.08%10M-15.38%11M26.83%52M9.09%12M16.67%14M44.44%13M
Non-operating interest expense 200.00%3M100.00%8M0.00%2M200.00%3M--2M0.00%1M100.00%4M--2M0.00%1M--0
Other net income (expense) -20M0
Special income (charges) ------0--0--0--0--0---20M--0--0--0
-Less:Impairment of capital assets ------0--0--0--0--0--20M--0--0--0
Income before tax -14.29%-128M-25.18%-353M-13.98%-106M-46.74%-135M0-2,700.00%-112M6.31%-282M-16.25%-93M-33.33%-92M-25.68%-93M
Income tax 000000-83.33%1M0.00%1M00
Net income -14.29%-128M-24.73%-353M-12.77%-106M-46.74%-135M0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M
Net income continuous Operations -14.29%-128M-24.73%-353M-12.77%-106M-46.74%-135M--0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M
Minority interest income
Net income attributable to the parent company -14.29%-128M-24.73%-353M-12.77%-106M-46.74%-135M0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.29%-128M-24.73%-353M-12.77%-106M-46.74%-135M0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M
Basic earnings per share 10.53%-1.02-4.78%-3.2913.59%-0.89-27.00%-1.270-2,180.00%-1.1424.34%-3.144.63%-1.03-6.38%-11.92%-1.02
Diluted earnings per share 10.53%-1.02-4.78%-3.2913.59%-0.89-27.00%-1.270-2,180.00%-1.1424.34%-3.144.63%-1.03-6.38%-11.92%-1.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More